Literature DB >> 7989296

Angiotensinogen-deficient mice with hypotension.

K Tanimoto1, F Sugiyama, Y Goto, J Ishida, E Takimoto, K Yagami, A Fukamizu, K Murakami.   

Abstract

The renin-angiotensin system is an enzymatic cascade that produces a potent vasoconstrictor octapeptide angiotensin II, through its physiologically inactive intermediate decapeptide angiotensin I, from their precursor angiotensinogen. In the present study, we generated angiotensinogen-deficient mice by homologous recombination in mouse embryonic stem cells. These mice do not produce angiotensinogen in the liver, resulting in the complete loss of plasma immunoreactive angiotensin I. The systolic blood pressure of the homozygous mutant mice was 66.9 +/- 4.1 mm Hg, significantly lower than that of wild-type mice (100.4 +/- 4.4 mm Hg). This profound hypotension in angiotensinogen-deficient mice demonstrates an indispensable role for the renin-angiotensin system in maintaining blood pressure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989296

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  92 in total

Review 1.  Knockout of renin-angiotensin system genes: effects on vascular development.

Authors:  D Methot; T L Reudelhuber
Journal:  Curr Hypertens Rep       Date:  2001-02       Impact factor: 5.369

Review 2.  Designing antisense to inhibit the renin-angiotensin system.

Authors:  D Mohuczy; M I Phillips
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

3.  Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice.

Authors:  Frederique Yiannikouris; Michael Karounos; Richard Charnigo; Victoria L English; Debra L Rateri; Alan Daugherty; Lisa A Cassis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-09       Impact factor: 3.619

4.  Transgenic mice with -6A haplotype of the human angiotensinogen gene have increased blood pressure compared with -6G haplotype.

Authors:  Sudhir Jain; Andrej Tillinger; Brahmaraju Mopidevi; Varunkumar G Pandey; Chetankumar K Chauhan; Steven N Fiering; Soren Warming; Ashok Kumar
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

5.  Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice.

Authors:  Y Inokuchi; T Morohashi; I Kawana; Y Nagashima; M Kihara; S Umemura
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 6.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

7.  Novel mechanism of blood pressure regulation by forkhead box class O1-mediated transcriptional control of hepatic angiotensinogen.

Authors:  Yajuan Qi; Kebin Zhang; Yuxin Wu; Zihui Xu; Qian Chen Yong; Rajesh Kumar; Kenneth M Baker; Qinglei Zhu; Shouwen Chen; Shaodong Guo
Journal:  Hypertension       Date:  2014-07-28       Impact factor: 10.190

Review 8.  Male infertility and the genetics of spermatogenesis.

Authors:  M Okabe; M Ikawa; J Ashkenas
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

9.  Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation.

Authors:  F Niimura; P A Labosky; J Kakuchi; S Okubo; H Yoshida; T Oikawa; T Ichiki; A J Naftilan; A Fogo; T Inagami
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 10.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.